Activation of the AMPK/AKT/GSK-3β signaling pathway has been found to protect the myocardial ischemia-reperfusion injury and enhance glucose homeostasis in the diabetic liver (Yu et al., 2017; Chen et al., 2020). Here, GSK3B is linked to myocardial ischemia.